These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
479 related articles for article (PubMed ID: 16211215)
1. Survivin gene expression is negatively regulated by the p53 tumor suppressor gene in non-small cell lung cancer. Nakano J; Huang CL; Liu D; Ueno M; Sumitomo S; Yokomise H Int J Oncol; 2005 Nov; 27(5):1215-21. PubMed ID: 16211215 [TBL] [Abstract][Full Text] [Related]
2. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients. Liu D; Huang CL; Kameyama K; Hayashi E; Yamauchi A; Sumitomo S; Yokomise H Cancer; 2002 Apr; 94(8):2239-47. PubMed ID: 12001123 [TBL] [Abstract][Full Text] [Related]
3. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer. Huang CL; Liu D; Nakano J; Yokomise H; Ueno M; Kadota K; Wada H Clin Cancer Res; 2007 Dec; 13(23):6938-46. PubMed ID: 18056168 [TBL] [Abstract][Full Text] [Related]
4. Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer. Tanabe H; Yagihashi A; Tsuji N; Shijubo Y; Abe S; Watanabe N Lung Cancer; 2004 Dec; 46(3):299-304. PubMed ID: 15541814 [TBL] [Abstract][Full Text] [Related]
5. Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients. Kameyama K; Huang CL; Liu D; Masuya D; Nakashima T; Sumitomo S; Takami Y; Kinoshita M; Yokomise H Clin Cancer Res; 2003 Oct; 9(13):4926-34. PubMed ID: 14581367 [TBL] [Abstract][Full Text] [Related]
6. Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics. Gorgoulis VG; Zacharatos P; Mariatos G; Liloglou T; Kokotas S; Kastrinakis N; Kotsinas A; Athanasiou A; Foukas P; Zoumpourlis V; Kletsas D; Ikonomopoulos J; Asimacopoulos PJ; Kittas C; Field JK Cancer Res; 2001 Jan; 61(2):538-49. PubMed ID: 11212247 [TBL] [Abstract][Full Text] [Related]
7. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer. Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113 [TBL] [Abstract][Full Text] [Related]
8. Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer. Boldrini L; Faviana P; Pistolesi F; Gisfredi S; Di Quirico D; Lucchi M; Mussi A; Angeletti CA; Baldinotti F; Fogli A; Simi P; Basolo F; Fontanini G Oncogene; 2001 Oct; 20(45):6632-7. PubMed ID: 11641789 [TBL] [Abstract][Full Text] [Related]
9. Wnt3 gene expression promotes tumor progression in non-small cell lung cancer. Nakashima N; Liu D; Huang CL; Ueno M; Zhang X; Yokomise H Lung Cancer; 2012 May; 76(2):228-34. PubMed ID: 22070884 [TBL] [Abstract][Full Text] [Related]
10. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan. Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413 [TBL] [Abstract][Full Text] [Related]
11. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Mirza A; McGuirk M; Hockenberry TN; Wu Q; Ashar H; Black S; Wen SF; Wang L; Kirschmeier P; Bishop WR; Nielsen LL; Pickett CB; Liu S Oncogene; 2002 Apr; 21(17):2613-22. PubMed ID: 11965534 [TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis]. Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638 [TBL] [Abstract][Full Text] [Related]
13. Induction of p53-regulated genes in lung cancer cells: implications of the mechanism for adenoviral p53-mediated apoptosis. Gu J; Zhang L; Swisher SG; Liu J; Roth JA; Fang B Oncogene; 2004 Feb; 23(6):1300-7. PubMed ID: 14676844 [TBL] [Abstract][Full Text] [Related]
14. Expression of MAGE-D4, a novel MAGE family antigen, is correlated with tumor-cell proliferation of non-small cell lung cancer. Ito S; Kawano Y; Katakura H; Takenaka K; Adachi M; Sasaki M; Shimizu K; Ikenaka K; Wada H; Tanaka F Lung Cancer; 2006 Jan; 51(1):79-88. PubMed ID: 16225959 [TBL] [Abstract][Full Text] [Related]
15. Up-regulation of survivin mRNA might be a marker for non-invasive detection of non-small cell lung cancer rather than for prognosis. Warnecke-Eberz U; Baldus SE; Bollschweiler E; Hoelscher AH; Metzger R Anticancer Res; 2008; 28(3A):1525-9. PubMed ID: 18630507 [TBL] [Abstract][Full Text] [Related]
16. Survivin and Smac gene expressions but not livin are predictors of prognosis in non-small cell lung cancer patients treated with adjuvant chemotherapy following surgery. Dai CH; Li J; Shi SB; Yu LC; Ge LP; Chen P Jpn J Clin Oncol; 2010 Apr; 40(4):327-35. PubMed ID: 20056675 [TBL] [Abstract][Full Text] [Related]
17. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells. Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065 [TBL] [Abstract][Full Text] [Related]
18. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer. Zhang Z; Ma J; Li N; Sun N; Wang C Ann Thorac Surg; 2006 Jul; 82(1):243-8. PubMed ID: 16798222 [TBL] [Abstract][Full Text] [Related]
19. X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression. Han Y; Wang Y; Xu HT; Yang LH; Wei Q; Liu Y; Zhang Y; Zhao Y; Dai SD; Miao Y; Yu JH; Zhang JY; Li G; Yuan XM; Wang EH Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):518-26. PubMed ID: 19735876 [TBL] [Abstract][Full Text] [Related]
20. Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma. Morinaga S; Nakamura Y; Ishiwa N; Yoshikawa T; Noguchi Y; Yamamoto Y; Rino Y; Imada T; Takanashi Y; Akaike M; Sugimasa Y; Takemiya S Oncol Rep; 2004 Dec; 12(6):1189-94. PubMed ID: 15547736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]